智客公社

标题: 经过数据发掘，发现癌症治疗的靶标的方法 [打印本页]

作者: 李渭清 时间: 2019-12-2 14:23
标题: 经过数据发掘，发现癌症治疗的靶标的方法
明天给大家分享一篇文献，看看作者是如何经过数据发掘，发现癌症治疗的靶标？

1

期刊引见

明天要引见的这篇文章是我们中国人发表在ONCOLOGY REPORTS上的文章，ONCOLOGY REPORTS 2017年的影响因子为3.04，算是3分的文章。

2

文章标题

Bioinformatic analysis suggests that UGT2B15 activates the Hippo‑YAP signaling pathway leading to the pathogenesis of gastric cancer

3

分析内容

首先，第一步，作者在GEO数据库上下载了三个研讨的数据：GSE54129，GSE79973，GSE56807，然后经过GEO数据库自带的工具GEO2R做差异表达分析，然后取交集的差异基因。

[attach]271226[/attach]

第二步，做GO富集分析

[attach]271227[/attach]

第三步，KEGG富集分析

[attach]271228[/attach]

第四步，PPI分析以及挑选hub基因

[attach]271229[/attach]

第五步，查看hub基因在各种条件的表达程度

[attach]271230[/attach]

第六步，停止生活分析

[attach]271231[/attach]

第七步，停止免疫组化检验

[attach]271232[/attach]

最后，作者得住结论：UGT2B15能作为癌症治疗的靶标。

4

文章摘要

附录原文的摘要：

Gastric cancer (GC) is one of the most common

malignancies that threatens human health. As the molecular

mechanisms unerlying GC are not completely understood,

identification of genes related to GC could provide new insights

into gene function as well as potential treatment targets. We

discovered that UGT2B15 may contribute to the pathogenesis

and progression of GC using GEO data and bioinformatic

analysis. Using TCGA data, UGT2B15 mRNA was found to be

significantly overexpressed in GC tissues; patients with higher

UGT2B15 had a poorer prognosis. It was further discovered that

UGT2B15 and FOXA1 were both upregulated, and UGT2B15

and Foxa1 were positively correlated in GC. It is known that

Foxa1 is a vital threshold to activate the Hippo‑YAP signaling

pathway. In addition, we suggest that a potential molecular

mechanisms includes UGT2B15 which may upregulate Foxa1,

activate the Hippo‑YAP signaling pathway and contribute to the

development of GC. Taken together, our findings demonstrate

that UGT2B15 may be an oncogene in GC and is a promising

therapeutic target for cancer treatment.

作者: 荬蔲 时间: 2019-12-2 20:42
看起来好像不错的样子

作者: 伟姐姐 时间: 2019-12-4 10:22
真羡慕你们这些有故事的人

作者: 好好的不行 时间: 2019-12-5 07:27
元芳你怎么看？

欢迎光临智客公社 (http://bbs.cnaiplus.com/)